Skip to content

Effect of High Intensity Electromagnetic Body Shaping on Profile of Metabolism in Obese Men

Efficacy of High Intensity Electromagnetic Body Shaping in Obese Men

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06024018
Enrollment
60
Registered
2023-09-05
Start date
2022-06-01
Completion date
2023-12-01
Last updated
2023-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Obesity

Brief summary

high intensity focused electromagnetic technology's secondary effects are observed in the fat (adipose). within 8 h of a treatment session, apoptotic levels in adipose increased 91.7%.8 In addition, after the application of the high intensity electromagnetic technique, there is an increase in the rapid release of free fatty acids, so it can be used in weight loss

Detailed description

sixty obese males will be grouped to: first group (30 males) and second group (30 males). first and second groups will undergo dietary caloric restriction (i.e low calorie diet) and will be instructed to walk 10,000 continuous steps every day using the pedometer application for 3 months. only the first group will will undergo high intensity electromagnetic technique on abdomen of males which will be 3 sessions per week for 3 months

Interventions

DEVICEhigh intensity electromagnetic technology device, diet restriction, and walking

thirty obese males (30 males) will undergo dietary caloric restriction and will be instructed to walk 10,000 continuous steps every day using the pedometer application for 3 months. Also they will undergo high intensity electromagnetic technique (40 minutes for every session) on abdomen of males which will be 3 sessions per week for 3 months

BEHAVIORALdiet restriction and walking

thirty obese males (30 males) will undergo dietary caloric restriction and will be instructed to walk 10,000 continuous steps every day using the pedometer application for 3 months.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
40 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* men with central obesity * BMI 30-34.9 kg/m2

Exclusion criteria

* metabolic /cardiovascular, pulmonary illnesses, musculoskeletal/neurological illness, autoimmune/psychological illnesses

Design outcomes

Primary

MeasureTime frameDescription
subcutaenous abdominal fat thickness12 weeksit will be measured using ultrasonography

Secondary

MeasureTime frameDescription
body mass index12 weeksit will be measured at morning with empty stomach and bladder
waist circumference12 weeksit will be measured using inelastic tape
cortisol12 weeksit is a stress hormone
high density lipoprotein12 weeksit will be measured in serum
low density lipoprotein12 weeksit will be measured in serum
visceral abdominal fat thickness12 weeksit will be measured using ultrasonography
cholesterol12 weeksit will be measured in serum
appearance of abdomen subscale of Body Q questionnaire12 weeksBODY-Q provides a set of scales focusing on topics that are relevant to weight
health related-quality-of-life subscale of Body Q questionnaire12 weeksit provids questions related to body image , physical function , psychological function , sexual function
eating related concerns subscale of Body Q questionnaire12 weeksit provids questions related to eating behavior , expectations weight loss
triglycerides12 weeksit will be measured in serum

Countries

Egypt

Contacts

Primary ContactAli MA Ismail, lecturer
ali.mohamed@pt.cu.edu.eg01005154209
Backup Contactebtahal ATEF RAMADAN Afya
dr.ebtehalpt@yahoo.com02 1024666329

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026